Co-delivery of curcumin and Bcl-2 siRNA to enhance therapeutic effect against breast cancer cells using PEI-functionalized PLGA nanoparticles

References

• Al-Mahmood S, Sapiezynski J, Garbuzenko OB, Minko T. 2018. Metastatic and triple-negative breast cancer: challenges and treatment options. Drug Deliv Transl Res. 8(5):1483–1507.
   PubMed Web of Science ®Google Scholar
• Arya G, Das M, Sahoo SKJB. 2018. Evaluation of curcumin loaded chitosan/PEG blended PLGA nanoparticles for effective treatment of pancreatic cancer. Biomed Pharmacother. 102:555–566.
   PubMed Web of Science ®Google Scholar
• Assani K, Neidhard-Doll A, Goswami T. 2022. Mechanical properties of nanoparticles in the drug delivery kinetics. J Pharm Biopharm Res. 4(1):248–255.
   Google Scholar
• Badrzadeh F, Akbarzadeh A, Zarghami N, Yamchi MR, Zeighamian V, Tabatabae FS, Taheri M, Kafil HS. 2014. Comparison between effects of free curcumin and curcumin loaded NIPAAm-MAA nanoparticles on telomerase and PinX1 gene expression in lung cancer cells. Asian Pac J Cancer Prev. 15(20):8931–8936.
   PubMedGoogle Scholar
• Bakhrushina E, Demina N. 2022. Implants as targeted drug delivery systems. Pharm Chem J. 56(3):396–402.
   Web of Science ®Google Scholar
• Chereddy KK, Coco R, Memvanga PB, Ucakar B, des Rieux A, Vandermeulen G, Préat V. 2013. Combined effect of PLGA and curcumin on wound healing activity. J Control Release. 171(2):208–215.
   PubMed Web of Science ®Google Scholar
• Davis ME, Chen Z, Shin DM. 2010. Nanoparticle therapeutics: an emerging treatment modality for cancer. In: Nanoscience and technology: a collection of reviews from nature journals p. 239–250.
   Google Scholar
• Ebrahimian M, Taghavi S, Mokhtarzadeh A, Ramezani M, Hashemi M. 2017. Co-delivery of doxorubicin encapsulated PLGA nanoparticles and Bcl-xL shRNA using alkyl-modified PEI into breast cancer cells. Appl Biochem Biotechnol. 183(1):126–136.
   PubMed Web of Science ®Google Scholar
• Elbassiouni FE, El-Kholy WM, Elhabibi E-SM, Albogami S, Fayad E. 2022. Comparative study between curcumin and nanocurcumin loaded PLGA on colon carcinogenesis induced mice. Nanomaterials. 12(3):324.
   Web of Science ®Google Scholar
• Fraguas-Sánchez A, Martín-Sabroso C, Fernández-Carballido A, Torres-Suárez A. 2019. Current status of nanomedicine in the chemotherapy of breast cancer. Cancer Chemother Pharmacol. 84(4):689–706.
   PubMed Web of Science ®Google Scholar
• Ghaffari M, Dehghan G, Baradaran B, Zarebkohan A, Mansoori B, Soleymani J, Ezzati Nazhad Dolatabadi J, Hamblin MR. 2020. Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells. Colloids Surf B Biointerfaces. 188:110762.
   PubMed Web of Science ®Google Scholar
• Ghalandarlaki N, Alizadeh AM, Ashkani-Esfahani S. 2014. Nanotechnology-applied curcumin for different diseases therapy. Biomed Res Int. 2014:394264.
   PubMed Web of Science ®Google Scholar
• Goodman MD, McPartland S, Detelich D, Saif MW. 2016. Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy. J Gastrointest Oncol. 7(1):45–57.
   PubMedGoogle Scholar
• Gowda R, Jones NR, Banerjee S, Robertson GP. 2013. Use of nanotechnology to develop multi-drug inhibitors for cancer therapy. J Nanomed Nanotechnol. 04(06) :184.
   Google Scholar
• Hussain S, Tyagi S, Kaur G. 2022. Editorial on side effects used as therapeutic therapy of certain medications. J Drugs Addict Therap. 119:2–3.
   Google Scholar
• Hussain Y, Alam W, Ullah H, Dacrema M, Daglia M, Khan H, Arciola CR. 2022. Antimicrobial potential of curcumin: therapeutic potential and challenges to clinical applications. Antibiotics. 11(3):322.
   Google Scholar
• Jeengar MK, Shrivastava S, Veeravalli SCM, Naidu V, Sistla R. 2016. Amelioration of FCA induced arthritis on topical application of curcumin in combination with emu oil. Nutrition. 32(9):955–964.
   PubMed Web of Science ®Google Scholar
• Jeon SY, Park JS, Yang HN, Woo DG, Park K-H. 2012. Co-delivery of SOX9 genes and anti-Cbfa-1 siRNA coated onto PLGA nanoparticles for chondrogenesis of human MSCs. Biomaterials. 33(17):4413–4423.
   PubMed Web of Science ®Google Scholar
• Kunnumakkara AB, Harsha C, Banik K, Vikkurthi R, Sailo BL, Bordoloi D, Gupta SC, Aggarwal BB. 2019. Is curcumin bioavailability a problem in humans: lessons from clinical trials. Expert Opin Drug Metab Toxicol. 15(9):705–733.
   PubMed Web of Science ®Google Scholar
• Labieniec-Watala M, Watala C. 2015. PAMAM dendrimers: destined for success or doomed to fail? Plain and modified PAMAM dendrimers in the context of biomedical applications. J Pharm Sci. 104(1):2–14.
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. 2011. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers. 3(3):1377–1397.
   PubMed Web of Science ®Google Scholar
• Mathew A, Fukuda T, Nagaoka Y, Hasumura T, Morimoto H, Yoshida Y, Maekawa T, Venugopal K, Kumar DS. 2012. Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer’s disease. PLOS One. 7(3):e32616.
   PubMed Web of Science ®Google Scholar
• Park JS, Yang HN, Woo DG, Jeon SY, Do H-J, Lim H-Y, Kim J-H, Park K-H. 2011. Chondrogenesis of human mesenchymal stem cells mediated by the combination of SOX trio SOX5, 6, and 9 genes complexed with PEI-modified PLGA nanoparticles. Biomaterials. 32(14):3679–3688.
   PubMed Web of Science ®Google Scholar
• Park K, Skidmore S, Hadar J, Garner J, Park H, Otte A, Soh BK, Yoon G, Yu D, Yun Y, et al. 2019. Injectable, long-acting PLGA formulations: analyzing PLGA and understanding microparticle formation. J Control Release. 304:125–134.
   PubMed Web of Science ®Google Scholar
• Paskeh MDA, Saebfar H, Mahabady MK, Orouei S, Hushmandi K, Entezari M, Hashemi M, Aref AR, Hamblin MR, Ang HL, et al. 2022. Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy. Life Sci. 298:120463.
   PubMed Web of Science ®Google Scholar
• Prabhuraj R, Bomb K, Srivastava R, Bandyopadhyaya R. 2020. Dual drug delivery of curcumin and niclosamide using PLGA nanoparticles for improved therapeutic effect on breast cancer cells. J Polym Res. 27(5) :1–13.
   Web of Science ®Google Scholar
• Salehi M, Movahedpour A, Tayarani A, Shabaninejad Z, Pourhanifeh MH, Mortezapour E, Nickdasti A, Mottaghi R, Davoodabadi A, Khan H, et al. 2020. Therapeutic potentials of curcumin in the treatment of non‐small‐cell lung carcinoma. Phytother Res. 34(10):2557–2576.
   PubMed Web of Science ®Google Scholar
• Sanlier N, Kocabas Ş, Erdogan K, Sanlier NT. 2022. Effects of curcumin, its analogues, and metabolites on various cancers: focusing on potential mechanisms. Food Rev Int. :1–21.
   Google Scholar
• Sarkar C, Kommineni N, Butreddy A, Kumar R, Bunekar N, Gugulothu K. 2022. PLGA nanoparticles in drug delivery. Nanoengineering of Biomaterials: Drug Delivery. 1:217–260.
   Google Scholar
• Senapati S, Mahanta AK, Kumar S, Maiti P. 2018. Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduct Target Ther. 3(1):7–19.
   PubMed Web of Science ®Google Scholar
• Seo EJ, Jang IH, Do EK, Cheon HC, Heo SC, Kwon YW, Jeong GO, Kim BR, Kim JH. 2013. Efficient production of retroviruses using PLGA/bPEI-DNA nanoparticles and application for reprogramming somatic cells. PLOS One. 8(9):e76875.
   PubMed Web of Science ®Google Scholar
• Su W-P, Cheng F-Y, Shieh D-B, Yeh C-S, Su W-C. 2012. PLGA nanoparticles codeliver paclitaxel and Stat3 siRNA to overcome cellular resistance in lung cancer cells. Int J Nanomed. 7:4269–4283.
   PubMed Web of Science ®Google Scholar
• Tabatabaei Mirakabad FS, Akbarzadeh A, Milani M, Zarghami N, Taheri-Anganeh M, Zeighamian V, Badrzadeh F, Rahmati-Yamchi M. 2016. A Comparison between the cytotoxic effects of pure curcumin and curcumin-loaded PLGA-PEG nanoparticles on the MCF-7 human breast cancer cell line. Artif Cells Nanomed Biotechnol. 44(1):423–430.
   PubMed Web of Science ®Google Scholar
• Tabatabaei SM, Taheri Soodejani M, Shoraka HR, Mahmoudimanesh M, Eslami S, Ghaderi A. 2022. Incidence of breast and cervical intraepithelial lesions: results of a screening program for women. J Obstet Gynecol Cancer Res. 7(3):200–205.
   Google Scholar
• Tekedereli I, Alpay SN, Akar U, Yuca E, Ayugo-Rodriguez C, Han H-D, Sood AK, Lopez-Berestein G, Ozpolat B. 2013. Therapeutic silencing of Bcl-2 by systemically administered siRNA nanotherapeutics inhibits tumor growth by autophagy and apoptosis and enhances the efficacy of chemotherapy in orthotopic xenograft models of ER (−) and ER (+) breast cancer. Mol Ther Nucleic Acids. 2:e121.
   PubMedGoogle Scholar
• Uyanik O, Pekkoc-Uyanik KC, Findik S, Avci A, Altuntas Z. 2022. Prevention of peritendinous adhesions with electrospun poly (lactic acid-co-glycolic acid)(PLGA) bioabsorbable nanofiber: an experimental study. Colloids Surf B Biointerfaces. 209(Pt 2):112181.
   PubMedGoogle Scholar
• Vallianou NG, Evangelopoulos A, Schizas N, Kazazis C. 2015. Potential anticancer properties and mechanisms of action of curcumin. Anticancer Res. 35(2):645–651.
   PubMed Web of Science ®Google Scholar